Executive leadership at EBR Systems.
Board of directors at EBR Systems.
Research analysts covering EBR Systems.
Recent press releases and 8-K filings for EBRCZ.
EBR Systems, Inc. Announces Preliminary Q4 and Full Year 2025 Results and Commercial/Clinical Progress
EBRCZ
Earnings
Guidance Update
Product Launch
- EBR Systems, Inc. announced preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.
- The company expects to report Q4 2025 revenue in the range of US$870K and US$935K, and total 2025 revenue between US$1,552K and $1,617K.
- Commercial momentum continued in Q4 2025, with case volumes doubling from Q3 2025, 18 commercial patients implanted with the WiSE® System, and 9 incremental purchase agreements signed.
- Clinical progress included the commencement of the WiSE-UP post-approval study with 4 patient enrolments and the start of the TLC-AU feasibility study with the first patient enrolled in Q4 2025.
Jan 13, 2026, 11:01 AM
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more